49:357981.22 Biricova V, Laznickova A. Dendrimers: analytical characteriz 。

33、ation and applications. Bioorganic Chemistry 2009;
37:18592.23 Agrawal P, Gupta U, Jain NK. Glycoconjugated peptide dendrimers based nanoparticulate system for the delivery of chloroquine phosphate. Biomaterials 2007;
28:334959.24 Menjoge AR, Kannan RM, Tomalia DA. Dendrimer-based drug and imaging con 。

34、jugates: design considerations for nanomedical applications. Drug Discovery Today 2010;
15:17185.25 Kesharwani P, ekade RK, Gajbhiye V, Jain K, Jain NK. Cancer targeting potential of some ligand-anchored poly(propylene imine) dendrimers: a comparison. Nanomedicine 2011;
7:295304.26 Agrawal A, Gupta U, 。

35、 Asthana A, Jain NK. Dextran conjugated dendritic nanoconstructs as potential vectors for anti-cancer agent. Biomaterials 2009;
30:358896.27 Shi X, Banyai IN, Lesniak WG, Islam MT, Ogh IN, Balogh P, Baker JR, Balogh Jr LP. Capillary electrophoresis of polycationic poly (amidoamine) dendrimers. Electr 。

36、ophoresis 2005;
26:294959.28 Rupp R, Rosenthal SL, Stanberry LR. VivaGel (SPL7013 Gel): a candidate dendrimer-microbicide for the prevention of HIV and HSV infection. International Journal of Nanomedicine 2007;
2:5616.29 Tyssen D, Henderson SA, Johnson A, Sterjovski J, Moore K, La J, Zanin M, Sonza S, 。

【树状大分子作为药物运载体系的研究进展|树状大分子作为药物运载体系的研究进展 - 副本 - 副本】37、 Karellas P, Giannis MP, Krippner G, Wesselingh S, McCarthy T, Gorry PR, Ramsland PA, Cone R, Paull JR, Lewis GR, Tachedjian G. Structure activity relationship of dendrimer microbicides with dual action antiviral activity. PLoS ONE 2010;
5:e1230930 Jain NK, Gupta U. Application of dendrimer-drug comp 。

38、lexation in the enhancement of drug solubility and bioavailability. Expert Opinion on Drug Metabolism & Toxicology 2008;
4:103552.31 Cheng Y, Man N, Xu T, Fu R, Wang X, Wang X, Wen L. Transdermal delivery of nonsteroidal anti-inflammatory drugs mediated by polyamidoamine (PAMAM) dendrimers. Journal o 。

39、f Pharmaceutical Sciences 2007;
96:595602.32 Najlah M, Freeman S, Attwood D, DEmanuele A. In vitro evaluation of dendrimer prodrug for oral drug delivery. International Journal of Pharmaceutics 2007;
336:18390.33 Goldberg DS, Vijayalakshmi N, Swaan PW, Ghandehari H. G3.5 PAMAM dendrimers enhance trans 。

40、epithelial transport of SN38 while minimizing gastrointestinal toxicity. Journal of Controlled Release 2011;
150:31825.34 Jain K, Kesharwani P, Gupta U, Jain NK. A review of glycosylated carriers for drug delivery. Biomaterials 2012;
33:416686.35 Tolia GT, Choi HH. The role of dendrimers in topical dr 。

41、ug delivery Pharmaceutical Technology 2008;
32:8898.36 Gajbhiye V, Ganesh N, Barve J, Jain NK. Synthesis, characterization and targeting potential of zidovudine loaded sialic acid conjugated-mannosylated poly(propyleneimine) dendrimers. European Journal of Pharmaceutical Sciences 2013;
48:66879.37 Gra 。

42、rd HC, Mishra MK, Mao G, Wang S, Hali M, Whittum-Hudson JA, Kannan RM, Hudson AP. Dendrimer-enabled DNA delivery and transformation of Chlamydia pneumoniae. Nanomedicine 2013;
7:996-100838 Bosnjakovic A, Mishra MK, Ren W, Kurtoglu YE, Shi T, Fan D, Kannan RM. Poly(amidoamine) dendrimer-erythromycin c 。

43、onjugates for drug delivery to macrophages involved in periprosthetic inflammation. Nanomedicine 2011;
7:28494.39 Mishra MK, Kotta K, Hali M, Wykes S, Gerard HC, Hudson AP, Whittum-Hudson JA, Kannan RM. PAMAM dendrimerazithromycin conjugate nanodevices for the treatment of Chlamydia trachomatis infec 。

44、tions. Nanomedicine 2011;
7:93544.40 Kitamatsu M, Kitabatake M, Noutoshi Y, Ohtsuki T. Synthesis and properties of peptide dendrimers containing fluorescent and branched amino acids. Biopolymers 2013;
100:6470.41 Chan C, Cai Z, Reilly RM. Trastuzumab labeled to high specific activity with111 In by con 。

45、jugation to G4 PAMAM dendrimers derivatized with multiple DTPA chelators exhibits ncreased cytotoxic potency on HER2-positive breast cancer cells. Pharmaceutical Research 2013;
30:19992009.42 Mutalik S, Parekh HS, Anissimov YG, Grice JE, Roberts MS. Iontophoresis-mediated transdermal permeation of pe 。

46、ptide dendrimers across human epidermis. Skin Pharmacology & Physiology 2013;
26:12738.43 Shen Y, Xu Q, Gao H, Zhu N. Dendrimer-encapsulated Pd nanoparticles anchored on carbon nanotubes for electro-catalytic hydrazine oxidation. Electrochemistry Communications 2009;
11:132932.44 Li C, Li D, Zhao ZS,。

47、Duan XM, Hou W. Platinum nanoparticles from hydrosilylation reaction: carbosilane dendrimer as capping agent. Colloids and Surfaces A: Physiochemical and Engineering Aspects 2010;
366:459.45 Qin W, Yang K, Tang H, Tan L, Xie Q, Ma M, Zhang Y, Yao S. Improved GFP gene transfection mediated by polyamidoamine dendrimer-functionalized multi-walled carbon nanotubes with high biocompatibility. Colloids and Surfaces B:Biointerfaces 2011;

稿源：(未知)

【傻大方】网址：/a/2021/0801/0023375091.html

标题：树状大分子作为药物运载体系的研究进展|树状大分子作为药物运载体系的研究进展 - 副本 - 副本( 五 )